Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
BCG from Calmette-Guerin strain | Injection | N/A | |
filgrastim | Injection | 300 mcg/ml | |
flutamide | Tablet | 250 mg | |
interferon alpha 2B | Injection | 18 000 000 UI | |
letrozol | Tablet | 2.5 mg | |
leuprorelin | Injection | 3.75 mg (acetate) | |
tamoxifen | Tablet | 20 mg (as citrate) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
chlorambucil | Tablet | 2 mg | |
cyclophosphamide | Injection | 500 mg | |
cyclophosphamide | Tablet | 50 mg | |
dacarbazine | Injection | 200 mg | |
ifosfamide | Injection | 1 g | |
melphalan | Tablet | 2 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
etoposide | Injection | 20 mg/mL | |
vinblastine | Injection | 10 mg | |
vincristine | Injection | 1 mg/mL |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
capecitabine | Tablet | 500 mg | |
citarabine | Injection | 100 mg | |
citarabine | Injection | 500 mg | |
fluorouracil | Injection | 500mg/10ml | |
gemcitabine | Injection | 1g (chlorohydrate) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
fludarabine | Injection | 50 mg (phosphate) | |
mercaptopurine | Tablet | 50 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
dactinomycin | Solution for injection | 0.5 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
methotrexate | Injection | 500mg (sodium) | |
methotrexate | Solution for injection | 25 mg/ ml |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
doxorubicin | Powder for injection | 50 mg (hydrochloride) in vial | |
mitoxantrone | Injection | 2 mg/mL |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
imatinib | Tablet | 100 mg (as mesylate) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
rituximab | Solution for injection | 10 mg/ ml |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
asparaginase | Injection | 10000 UI | |
hydroxyurea | Capsule | 500 mg | |
retinoic acid | Capsule | 10 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
carboplatin | Injection | 150 mg | |
carboplatin | Injection | 450 mg | |
cisplatin | Injection | 50 mg | |
oxaliplatin | Injection | 100 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
paclitaxel | Powder for injection | 6 mg/ml |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
filgrastim | Injection | 300 mcg/ml | |
interferon alpha 2B | Injection | 18 000 000 UI |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
azathioprine | Tablet | 50 mg | |
basiliximab | Injection | 10 mg | |
cyclosporine | Solution | 100 mg/ml | |
leflunomide | Tablet | 20 mg | |
methotrexate | Tablet | 2.5 mg | |
mycophenolate mofetil | Tablet | 250 mg | |
tacrolimus | Tablet | 1 mg | |
talidomida | Tablet | 100 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
amikacin | Injection | 250 mg/ml | |
amoxicillin | Oral liquid | 250 mg/5 mL | |
amoxicillin | Tablet | 500 mg | |
amoxicillin + clavulanic acid | Oral liquid | 250 mg amoxicillin + 62.5 mg clavulanic acid/5 ml | |
amoxicillin + clavulanic acid | Tablet | 500 mg (as trihydrate) + 125 mg (as potassium salt) | |
ampicillin | Powder for injection | 1 g (as sodium salt) in vial | |
ampicillin + sulbactam | Powder for injection | 1 g (sodium) + 0.5 g (sodium) | |
azithromycin | Oral liquid | 200 mg/5 mL | |
azithromycin | Tablet | 500 mg | |
benzathine benzylpenicillin | Injection | 1 200 000 IU | |
cefadroxil | Capsule | 500mg | |
cefadroxil | Oral liquid | 250mg/5ml | |
cefazolin | Injection | 1g | |
cefotaxime | Injection | 1 g | |
ceftazidime | Powder for injection | 1 g (as pentahydrate) in vial | |
ceftriaxone | Powder for injection | 1 g (as sodium salt) in vial | |
Chloranfenicol | Capsule | 1 gr (sodium succinate) | |
ciprofloxacin | Injection | 2mg (lactate)/ml | |
ciprofloxacin | Tablet | 500mg (as chlorohydrate) | |
clarithromycin | Suspension | 250 mg/5 ml | |
clarithromycin | Tablet | 500 mg | |
clindamycin | Injection | 150 mg (as phosphate)/mL | |
clindamycin | Oral liquid | 75 mg/5 mL (as palmitate) | |
clindamycin | Tablet | 300 mg | |
dicloxacillin | Tablet | 250mg | |
doxycycline | Capsule | 100 mg (as hydrochloride or hyclate) | |
gentamicin | Injection | 40 mg/ml | |
imipenem + cilastatin | Powder for injection | 500 mg (as monohydrate) + 500 mg (as sodium salt) in vial | |
kanamycin | Injection | 500 mg | |
kanamycin | Powder for injection | 1 g (as sulfate) in vial | |
levofloxacin | Injection | 5 mg/ ml | |
levofloxacin | Injection | 500 mg | |
linezolid | injection for intravenous administration | 2 mg/ ml | |
linezolid | Tablet | 600 mg | |
meropenem | Powder for injection | 1 g | |
meropenem | Powder for injection | 500mg | |
metronidazole | Injection | 5 mg/mL | |
moxifloxacin | Tablet | 400 mg | |
nitrofurantoin | Oral suspension | 50mg/5ml | |
nitrofurantoin | Tablet | 100 mg | |
oxacillin | Injection | 1g | |
penicillin G (Sodium) | Powder for injection | 5 MUI | |
phosphomycin | Capsule | 500 mg | |
piperacillin sodium + tazobactum sodium | Solution for injection | 4 g/ 500 mg | |
streptomycin | Powder for injection | 1 g | |
sulfadiazine | Tablet | 500 mg | |
sulfamethoxazole + trimethoprim | Oral liquid | 200 mg + 40 mg/5 mL | |
sulfamethoxazole + trimethoprim | Tablet | 800 mg + 160 mg | |
vancomycin | Injection | 500 mg (chlorohydrate) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
clofazimine | Capsule | 100 mg | |
clofazimine | Capsule | 50 mg | |
cycloserine | Capsule | 250 mg | |
dapsone | Tablet | 100 mg | |
ethambutol | Tablet | 400mg (chlorohydrate) | |
ethambutol + isoniazid + pyrazinamide + rifampicin | Tablet | 275 mg + 75 mg + 400 mg + 150 mg | |
ethionamide | Tablet | 250 mg | |
ethionamide | Tablet | 500 mg | |
isoniazid | Oral liquid | 50 mg/5 ml | |
isoniazid | Tablet | 100mg | |
isoniazid | Tablet | 300mg | |
isoniazid + rifampicin | Tablet | 150 mg + 150 mg | |
p-aminosalicylic acid | Granules | 4 g in sachet | |
p-aminosalicylic acid | Tablet | 500 mg | |
pyrazinamide | Tablet | 500 mg | |
rifampicin | Capsule | 300 mg | |
rifampicin | Suspension | 100mg/5ml |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
amphotericin B | Injection | 50 mg | |
fluconazole | Capsule | 50 mg | |
fluconazole | Injection | 2 mg/mL in vial | |
fluconazole | Injection | 200 mg | |
itraconazole | Tablet | 100 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
abacavir (ABC) | Tablet | 300 mg | |
aciclovir | Oral liquid | 200 mg/5 mL | |
aciclovir | Tablet | 250 mg | |
aciclovir | Tablet | 400 mg | |
atazanavir | Solid oral dosage form | 300 mg (as sulfate) | |
darunavir | Tablet | 600 mg | |
didanosine (ddI) | Capsule (unbuffered enteric-coated) | 125 mg | |
didanosine (ddI) | Capsule (unbuffered enteric-coated) | 250 mg | |
didanosine (ddI) | Capsule (unbuffered enteric-coated) | 400 mg | |
didanosine (ddI) | Powder for oral administration | 4g | |
efavirenz (EFV or EFZ) | Capsule | 200 mg | |
efavirenz (EFV or EFZ) | Tablet | 600 mg | |
efavirenz (EFV or EFZ) | Tablet | 600 mg | |
efavirenz + emtricitabine + tenofovir | Tablet | 600 mg + 200 mg + 300 mg | |
emtricitabine + tenofovir | Tablet | 200 mg + 300 mg | |
estavudina | Capsule | 30 mg | |
etravirine | Tablet | 100 mg | |
ganciclovir | Injection | 500 mg (sodium) | |
indinavir (IDV) | Solid oral dosage form | 400 mg (as sulfate) | |
lamivudine (3TC) | Oral liquid | 50 mg/5 ml | |
lamivudine (3TC) | Tablet | 150 mg | |
lamivudine + zidovudine | Tablet | 150 mg + 300 mg | |
lopinavir + ritonavir (LPV/r) | Oral liquid | 80 + 20 mg/ml | |
lopinavir + ritonavir (LPV/r) | Tablet | 200 mg/ 50 mg | |
nelfinavir | Oral liquid | 50mg (mesylate)/g | |
nelfinavir | Tablet | 250mg (as mesylate) | |
nevirapine (NVP) | Oral liquid | 50 mg/5 ml | |
nevirapine (NVP) | Tablet | 200 mg | |
oseltamivir | Capsule | 75 mg (as phosphate) | |
raltegavir | Tablet | 400 mg | |
ritonavir | Capsule | 100 mg | |
ritonavir | Oral liquid | 400 mg/5 ml | |
stavudine (d4T) | Capsule | 20 mg | |
stavudine (d4T) | Powder for oral liquid | 5 mg/5 ml | |
tenofovir disoproxil fumarate | Tablet | 300 mg | |
zidovudine (ZDV or AZT) | Capsule | 100 mg | |
zidovudine (ZDV or AZT) | Capsule | 300 mg | |
zidovudine (ZDV or AZT) | Suspension | 10 mg/ml | |
zidovudine (ZDV or AZT) | Suspension | 50 mg/5 ml |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
anti rabies human serum | Solution for injection | 150 UI/ ml | |
anti-D immunoglobulin (human) | Injection | 300 mcg/ ml | |
antitetanus immunoglobulin (human) | Intramuscular administration | 250 IU per vial | |
human normal immunoglobulin | Injectable solution | (5 - 6) g | |
human normal immunoglobulin | Injectable solution | 1 gr | |
ophidic antivenom | Solution for injection | N/A |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
cell-culture rabies vaccine | Injection | N/A | |
DT vaccine | Injection | N/A | |
DTP vaccine | Injection | Injectiondiphtheria-tetanus toxoid + whole inactivated B. pertussis cells | |
hepatitis B vaccine | Injection | N/A | |
measles vaccine | Injection | N/A | |
monovalent human atenuate rotavirus vaccine | Injection | 1 mL | |
pentavalent vaccine | Injection | diphtheria-tetanu toxoid, whole cell pertussis, hepatitis B, H. influenzae b (Hib) | |
pneumococcal vaccine -23 | Solution for injection | 0.5 mL - 1 dose | |
pneumococcal vaccine 10 valente | suspension inyectable | N/A | |
pneumococcal vaccine 13 valente | suspension inyectable | N/A | |
poliomyelitis vaccine | Injection | N/A | |
polyomelitis bivalent vaccine | Injection | 0.1 mL | |
Td Difteria Toxoid + Tetanus adsorbe vaccine | Injection | N/A | |
Tdap Acellular Triple Antibacterial Vaccine | Injection | D2LF, P2.5mcg,T5LF | |
trivalent anti-influenza vaccine | Injection | 0.5 mL (A+B+Subviron, Timerosal) | |
vero cells purified rabies vaccine | Injection | N/A | |
yellow fever vaccine | N/A | N/A |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
albendazole | Tablet | 200mg | |
mebendazole | Suspension | 100mg/5ml | |
mebendazole | Tablet | 100 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
benznidazole | Tablet | 100 mg | |
chloroquine | Tablet | 150mg (phosphate) | |
diloxanide | Oral suspension | (200-250)mg/5mL | |
diloxanide | Tablet | 500 mg (furoate) | |
hydroxychloroquine | Tablet | 400mg (sulfate) or 310mg (pure) | |
meglumine antimoniate | Injection | 300mg/ml | |
metronidazole | Suspension | 250 mg/5 mL | |
metronidazole | Tablet | 500 mg | |
nifurtimox | Tablet | 120 mg | |
primaquine | Tablet | 15 mg (phosphate) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
permethrin | Cream | 5% | |
permethrin | Lotion | 1% |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
neomycin + bacitracin | Cream | 5 mg (5000 UI) + 5 mg (250 UI) | |
silver sulfadiazine | Cream | 1% | |
sodium fusidate | Ointment | 2% (20 mg/g) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
clotrimazole | Cream | 1% |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
methoxsalen | Solution | 0.4% | |
methoxsalen | Tablet | 10 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
aluminum aulfate and aalcium acetate | Solution | (36.4 + 51.8) % | |
nitrofurazone | Cream | 0.2% |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
tretinoin | Cream | 0.05 g |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
betamethasone | Cream | 0.1% (as valerate) | |
hydrocortisone | Cream | 1% (acetate) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
acetazolamide | Tablet | 250 mg | |
aciclovir | Eye ointment | 3% | |
artificial tears | Solution (eye drops) | 0.3% to 1% | |
atropine | Solution (eye drops) | 0.5-1% | |
carbacol | eye drops | 0.01% | |
Chloranfenicol | eye drops | 0.5% | |
Chloranfenicol | eye drops | 1% | |
chloranfenicol + dexametasone phosphate | eye drops | 0.3%+0.1% | |
ciprofloxacin | Topical | 0.3% drops (as hydrochloride) | |
cromoglycate | Solution (eye drops) | 2% (sodium) | |
cyclopentolate | Solution (eye drops) | 1% (hydrochloride) | |
diclofenac | Solution (eye drops) | 0.1% (sodium) | |
dorzolamide | Solution (eye drops) | 2% | |
latanoprost | Solution (eye drops) | 0.005% | |
normal saline | Solution (eye drops) | 500 mL | |
oxitetracycline + plymyxine B | eye drops | (5 mg +10,000 U.I)/g | |
phenylephrine | dro | 10% | |
phenylephrine+tropicamide | Solution (eye drops) | 0.8% - 5 mL. | |
pilocarpine | Solution (eye drops) | 2% (hydrochloride or nitrate) | |
polyacrilic acid | eye drops | 0.2% | |
prednisolone | Solution (eye drops) | 1% (acetate) | |
tetracaine | Solution (eye drops) | 0.5% (hydrochloride) | |
timolol | Solution (eye drops) | 0.5% (maleate) | |
tobramycin | dro | 0.3% x 5 ml | |
tobramycin + dexamethasone | dro | 0.3%/ 0.1% x 5 ml | |
tropicamide | Solution (eye drops) | 0.5% | |
tropicamide | Solution (eye drops) | 1% |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
glycerine | N/A | N/A |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
dexamethasone | Injection | 4 mg/mL | |
fludrocortisone | Tablet | 0.1 mg | |
hydrocortisone | suspension inyectable | 500 mg | |
methylprednisolone | Injection | 1 gm | |
methylprednisolone | Injection | 500 mg (sodium succinate) | |
methylprednisolone | Tablet | 40 mg | |
prednisolone | Tablet | 5 mg | |
prednisone | Tablet | 50 mg | |
triamcinolone | Injection | 10 mg/mL in 5-mL vial |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
desmopressin | Nasal solution | 0.1 mg (acetate)/mL | |
octreotide | Solution for injection | 0.1 mg/mL - 1mL | |
oxytocin | Injection | 5 IU/mL |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
levothyroxine | Tablet | 100 mcg (sodium salt) | |
levothyroxine | Tablet | 50 mcg (sodium salt) | |
methimazole | Tablet | 5 mg | |
propylthiouracil | Tablet | 50 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
acetylsalicylic acid | Tablet | 80 to 100 mg | |
clopidogrel | Tablet | 75 mg | |
enoxaparin | Injection | 20 mg/ml | |
enoxaparin | Injection | 60 mg (sodium) | |
heparin sodium | Injection | 5000 IU/mL in 1-mL ampoule | |
streptokinase | Powder for injection | 1.5 million IU in vial | |
warfarin | Tablet | 5 mg (sodium salt) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
aminocaproic acid | Injection | 250mg/ml | |
factor IX | Powder for injection | 500 UI a 600 UI | |
factor VIII | Solution for injection | 500 UI | |
phytomenadione | Injection | 10 mg/mL in 1-mL vial | |
prothrombin complex concentrate | Injection | 500 a 600 UI | |
prothrombine activate complex (CCPa) or anticoagulant anti-inhibitor complex | Injection | 500 UF |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
cyanocobalamin | Injection | 1000 mcg/ml | |
erythropoietin alpha | Injection | 4000 U/ ml | |
erythropoietin beta | Solution for injection | 50000 UI | |
ferrous sulfate | Oral liquid | 125mg/ml | |
ferrous sulfate | Tablet | 300 mg | |
ferrous sulfate + folic acid | Tablet | 300mg + 0.5mg | |
folic acid | Tablet | 5 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
albumin | Injection | 20%-25% | |
calcium chloride | Injection | 5% | |
chloruro de sodio | Parenteral solution | 20% | |
chloruro de sodio | Solution for injection | 0.9 % | |
dextrose | Injection | 10% | |
dextrose | N/A | 5% | |
dextrose | N/A | 50% | |
dextrose + sodium chlorure | Solution for injection | 5% + 0.9% - 1000 mL. | |
dextrose + sodium chlorure | Solution for IV infusion | 5 + 0.3% | |
hemodialysis solution | Solution for IV infusion | N/A | |
hemodialysis solution (concentrated, acid, for bicarbonate hemodialysis) | N/A | N/A | |
intraperitoneal dialysis solution (of appropriate composition) | Parenteral formulation | 4.5% | |
intraperitoneal dialysis solution (of appropriate composition) | Solution for IV infusion | 2.5% glucose | |
magnesium sulfate | Injection | 50% x 2 ml | |
mannitol | Intravenous administration | 20% | |
peritoneal dialysis solution | Solution | Dextrose 1.5% - 2000 mL. | |
plasmatic volumen expander gelatin based | Solution | 3.5-4% | |
potassium chloride | Injection | 20 mEq/10 ml | |
potassium chloride | Solution | 2 mEq/ml | |
ringer lactate solution | N/A | N/A | |
sodium bicarbonate | Injection | 8.4% | |
sodium chloride + phenol (preservant) | Injection | 0.9 + 0.4% |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
atenolol | Tablet | 100 mg | |
esmolol | Injection | 250 mg/ml | |
propranolol | Injection | 1mg/ml | |
propranolol | Tablet | 10mg (hydrochloride) | |
propranolol | Tablet | 40 mg (hydrochloride) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
carvedilol | Tablet | 25 mg | |
carvedilol | Tablet | 6.25 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
amlodipine | Injection | 5 mg/mL | |
amlodipine | Tablet | 5 mg (besylate) | |
nifedipine | N/A | 30 mg | |
nifedipine | Tablet | 10 mg | |
nimodipine | Injection | 0.2 mg/mL | |
nimodipine | Tablet | 30 mg | |
nimodipine | Tablet | 30 mg. | |
verapamil | Injection | 2.5 mg/mL | |
verapamil | N/A | 240 mg | |
verapamil | Tablet | 80 mg (hydrochloride) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
enalapril | Tablet | 20 mg (maleate) | |
enalapril | Tablet | 5 mg (as hydrogen maleate) | |
Ibersartan | Tablet | 150 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
atorvastatine | Tablet | 10 mg | |
atorvastatine | Tablet | 40 mg (calcium salt) | |
ciprofibrato | Capsule | 100 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
hydralazine | Injection | 20 mg/ ml | |
hydralazine | Tablet | 50 mg (hydrochloride) | |
methyldopa | Tablet | 500mg | |
sodium nitroprusside | Injection | 25 mg/mL |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
furosemide | Injection | 10 mg/mL in 2-mL ampoule | |
furosemide | Tablet | 40 mg | |
hydrochlorothiazide | Tablet | 25 mg | |
spironolactone | Tablet | 100mg | |
spironolactone | Tablet | 25 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
amiodarone | Injection | 50 mg/ml | |
amiodarone | Tablet (HCI) | 200 mg (hydrochloride) | |
digoxin | eli | 0.05 mg/ml | |
digoxin | Injection | 0.25 mg/ml | |
digoxin | Tablet | 0.25 mg | |
dobutamine | Injection | 12.5mg (hydrochloride)/mL in 20 ml vial | |
dopamine | Injection | 40 mg/ml | |
ephedrine | Injection | 25 mg/ml | |
epinephrine (adrenaline) | Injection | 1 mg in 1-mL ampoule | |
glyceryl trinitrate | Patch | 18-25 mg | |
glyceryl trinitrate | Solution for injection | 5 mg/ ml | |
isosorbide dinitrate | Tablet | 40 mg | |
isosorbide dinitrate | Tablet (sublingual) | 5 mg | |
norepinephrine | Injection | 1 mg (bitartrate)/mL | |
phenylephrine | Injection | 10 mg in 1-mL ampoule |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
antihemorrhoidal preparation (corticosteroid + local anesthetic) | Ointment | 30 gr/ 60 gr. | |
polidocanol | Intravenous administration | 3% in 20-mL ampoule |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
clotrimazole | Vaginal cream | 1% | |
metronidazole | Gel | 0.75% |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
chorionic gonadotropin | Injection | 2500 UI | |
clomifene | Tablet | 50 mg (citrate) | |
conjugated estrogens | Tablet | 0.625 mg | |
danazol | Tablet | 200 mg | |
estradiol | Tablet | 1 mg | |
ethinylestradiol + levonorgestrel | Tablet | 30 mcg + 150 mcg | |
etonogestrel | implant | 68 mg. | |
levonorgestrel | implant | 75 mg | |
levonorgestrel | Tablet | 1.5 mg | |
medroxyprogesterone | Powder for injection | 150 mg in vial | |
norethisterone enantate + estradiol valerate | Injection | 50 mg/5 mg | |
progesterone | Tablet | 100 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
bromocriptine mesylate | Tablet | 2.5 mg | |
ergonovina maleato | Injection | 0.2 mg/ ml | |
misoprostol | Tablet | 200 mcg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
oxibutinine hidrochloride | Tablet | 5mg. | |
terazosin | Tablet | 5 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
alendronic acid | Tablet | 70mg (as alendronate sodium) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
allopurinol | Tablet | 300 mg | |
colchicine | Tablet | 0.5mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
diclofenac | Injection | 25 mg (sodium)/mL | |
diclofenac | Suspension | 15mg/5mL | |
diclofenac (sodium) | Tablet | 50mg | |
ibuprofen | Suspension | 100 mg/5 mL | |
ibuprofen | Tablet | 400 mg | |
indomethacin | Tablet | 25 mg | |
ketorolac | Injection | 30mg/ml |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
cisatracurium | Injection | 2 mg/ml | |
metocarbamol | Injection | 500mg | |
orfenadrine | Injection | 30mg (citrate)/ml in 2ml vial | |
pancuronium | Injection | 2 mg (bromuro)/mL | |
suxamethonium | Injection | 100mg/ml | |
suxamethonium | Injection | 500mg | |
Tizanidine hydrochloride | Tablet | 4 mg. | |
vecuronium | Injection | 4 mg (bromide)/mL in ampoule |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
acetaminofen | Tablet | 125 mg | |
acetaminofen | Tablet | 250 -300 mg | |
acetaminofen | Tablet | 500 mg | |
acetaminofen + oxycodone | Tablet | 325+5 mg | |
ergotamine + caffeine | Tablet | 1 mg (tartrate) + 100 mg | |
fentanyl | Injection | 0.05 mg/mL | |
morphine | Oral liquid | 10 mg (sulfate)/5 mL | |
morphine | Tablet | 30 mg (sulfate) | |
nalbuphine hydrochloride | Solution for injection | 10 mg/ml | |
oxycodone | Tablet | 10 mg | |
paracetamol + acetaminophen | Syrup | 120 mg/ 5 ml | |
pethidine | Injection | 50 mg (hydrochloride) in 1-mL ampoule | |
tramadol | Injection | 50 mg (hydrochloride)/mL | |
tramadol | Oral liquid | 100 mg (hydrochloride)/mL (as drops) | |
tramadol | Tablet | 50 mg (hydrochloride) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
bupivacaine | Injection | 0.5% (hydrochloride) in vial | |
bupivacaine + dextrosa | Injection | 0.5%/ 8% (80 mg/ ml) | |
etomidate | Injection | 2mg/ml | |
halothane | Inhalation | N/A | |
isoflurane | Inhalation | N/A | |
ketamine | Injection | 50 mg/mL | |
lidocaine | Injection | 2% (hydrochloride) in vial | |
lidocaine | Solution topical | 10% (100mg/mL) | |
lidocaine + epinephrine (adrenaline) | Injection | 2% | |
mepivacaina + epinefrina | Injection | 2% / 1:100 000 | |
mepivacaine | Dental cartridge | 3% | |
propofol | Injection | 10 mg/mL | |
propofol | Injection | 20 mg/mL | |
remifentanil | Injection | 2 mg | |
remifentanil | Injection | 5mg | |
sevoflurane | Inhalation | N/A | |
thiopental | Injection | 1 g (as sodium) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
carbamazepine | Tablet | 200 mg | |
clonazepam | Tablet | 2mg | |
levetiracetam | Tablet | 500 mg | |
oxcarbazepine | N/A | 60mg/mL | |
phenobarbital | Oral liquid | 20 mg/5mL (0.4%) | |
phenobarbital | Suspension | 65mg/mL | |
phenobarbital | Tablet | 100 mg | |
phenytoin | Injection | 50 mg/mL in 5-mL vial (sodium salt) | |
phenytoin | Solid oral dosage form | 100 mg (sodium salt) | |
phenytoin | Suspension | 125 mg/ 5 ml x 240 ml | |
topiramate | Tablet | 25 mg | |
valproic acid (sodium valproate) | Injection | 100mg/mL | |
valproic acid (sodium valproate) | Oral liquid | 250 mg/5 mL | |
valproic acid (sodium valproate) | Solution | 200 mg/ml | |
valproic acid (sodium valproate) | Tablet | 500 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
amantadine | Capsule | 100 mg | |
biperiden | Injection | 5 mg (lactate) in 1-ml ampoule | |
biperiden | Tablet | 2 mg (hydrochloride) | |
levodopa + carbidopa | Tablet | 250 mg + 25 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
methadone | Concentrate for oral liquid | 10 mg/ml (hydrochloride) | |
neostigmine | Injection | 0,5 mg/ml | |
pyridostigmine | Tablet | 60 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
amitriptyline | Tablet | 25 mg (hydrochloride) | |
caffeine citrate | Injection | 20 mg/ml | |
clomipramine | Tablet | 25 mg | |
duloxetine | Tablet | 60 mg | |
fluoxetine | Tablet | 20 mg | |
imipramine chlorohydrate | Tablet | 10 mg | |
imipramine chlorohydrate | Tablet | 25mg | |
memantina | Tablet | 10 mg | |
methylphenidate | Tablet | 10 mg (hydrochloride) | |
sertraline | Tablet | 50 mg (chlorohydrate) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
chlorpromazine | Injection | 25 mg (hydrochloride)/mL in 2-mL ampoule | |
chlorpromazine | Tablet | 100 mg (hydrochloride) | |
clozapine | Tablet | 100mg | |
diazepam | Injection | 5 mg/mL | |
flufenazine decanoate | N/A | 25mg/mL | |
haloperidol | Injection | 5 mg (decanoate)/mL | |
haloperidol | Oral liquid | 2 mg/mL | |
haloperidol | Tablet | 5 mg | |
lithium carbonate | Tablet | 300 mg | |
lorazepam | Tablet | 2 mg. | |
midazolam | Injection | 5 mg/mL | |
olanzapine | Tablet | 10 mg | |
risperidone | Solution | 1 mg/ml | |
risperidone | Tablet | 2mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
aminophylline | Injection | 25 mg/mL | |
beclometasone | Inhalation (aerosol) | 250 micrograms (dipropionate) per dose | |
beclometasone | Inhalation (aerosol) | 50 mcg (dipropionate) per dose (as CFC free forms) | |
budesonide | Solution for inhalation | 0.5 mg/ml x 2 ml | |
formoterol | Inhalation (aerosol) | 12 mcg | |
ipratropium bromide | Inhalation (aerosol) | 20 micrograms/metered dose | |
ipratropium bromide | Solution | 250 mcg/ ml | |
salbutamol | Inhalation (aerosol) | 100 mcg (as sulfate) per dose | |
salbutamol | respirator solution for use in nebulizers | 0.5% | |
theophylline | Tablet (prolonged release) | 250 mg | |
triamcinolone | Nasal spray | 55 mcg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
chlorphenamine | Injection | 10mg/ml | |
chlorphenamine | Oral liquid | 2mg/5ml | |
chlorphenamine | Tablet | 4 mg (hydrogen maleate) | |
dimenhydrinate | Injection | 50 mg/mL | |
dimenhydrinate | Tablet | 50 mg | |
diphenhydramine | Injection | 50 mg/mL | |
loratadine | Oral liquid | 5 mg/mL | |
loratadine | Tablet | 10 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
surfactant | Suspension for intratracheal instillation | 25 mg/ml |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
atropine | Injection | 0.5 mg (sulphate) in 1-mL ampoule | |
atropine | Injection | 5 mg/mL | |
hyoscine butylbromide | Injection | 20 mg/ml in 1-mL ampoule | |
hyoscine butylbromide | Tablet | 10mg | |
metoclopramide | Injection | 5 mg/ml (hydrochloride) | |
metoclopramide | Tablet | 10 mg (hydrochloride) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
omeprazole | Capsule | 20 mg | |
omeprazole | Capsule | 20 mg | |
omeprazole | Injection | 40 mg | |
ranitidine | Injection | 50 mg | |
ranitidine | Oral liquid | 75 mg/5 mL (as hydrochloride) | |
ranitidine | Tablet | 150 mg (as hydrochloride) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
carbon activado | N/A | N/A | |
loperamide | Solid oral dosage form | 2mg | |
nystatin | Oral suspension | 100 000 units/ ml | |
oral rehydration salts | Powder for dilution | 1 L | |
sulphasalazine enteric coated | Tablet | 500 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
ondansetron | Injection | 2 mg/ml | |
ondansetron | Solid oral dosage form | Eq 8 mg base |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
glibenclamide | Tablet | 5 mg | |
insulin soluble | N/A | 100 units/ml | |
metformin | Tablet | 850 mg (hydrochloride) | |
NPH insulin (intermediate-acting insulin) | Injection | 100 IU/mL |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
lactulose | Aqueous emulsion | 10g/15mL | |
psyllium Hydrofílic Muciloid Isphagula seeds | N/A | N/A | |
ricin oil | Oily solution | N/A | |
sodium phosphate monobasic sodium phosphate dibasic | Aqueous emulsion | (19+7)g/118mL | |
sodium phosphate monobasic sodium phosphate dibasic | enema | (16+6) % | |
sodium phosphate monobasic sodium phosphate dibasic | sodium phosphate monobasic sodium phosphate dibasic | (2.4 + 0.9) g/5 mL |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
calcium carbonate | Tablet | 600 mg | |
calcium gluconate | Injection | 10% | |
zinc | Oral liquid | 10mg/5ml |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
bile salts | N/A | N/A |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
ascorbic acid | Tablet | 500 mg | |
calcitriol | Capsule | 0.25 mcg | |
calcitriol | Capsule | 50000 UI | |
multivitamins | Oral liquid | N/A | c2 |
multivitamins | Powder for injection | N/A | |
multivitamins | Tablet | N/A | |
pyridoxine | Tablet | 50mg (chlorohydrate) | |
thiamine | Injection | 100mg (chlorohydrate)/ml | |
thiamine | Tablet | 100mg | |
vitamin E | Capsule | 400 mg | c2 |
vitamin E | Powder sachet | 400 UI | c2 |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
tuberculin, purified protein derivative (PPD) | Subcutaneous administration | 2 TU/0.1 mL |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
amino acids | Parenteral formulation | 10% | |
amino acids | Parenteral solution | 3% with gycerol and electrolites | |
amino acids | Solution | < 6mEq/L< 5.4 mEq/L, Cloro < 3mEq/L 6% | |
lipid emulsion | Injection | 20% | |
oligoelements | Parenteral solution | for nutrition, according to availability |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
acetylcysteine | Oral liquid | 20% | |
calcium acetate | Tablet | 450-500mg | |
calcium folinate | Injection | 10 mg/ml | |
deferoxamine | Powder for injection | 500 mg | |
dimercaprol | Injection in oil | 50 mg/mL in 2-mL ampoule | |
flumazenil | Injection | 0.1 mg/ml | |
mesna | Injection | 100 mg/ml | |
methylene blue | Aqueous solution | 1% | |
naloxone | Injection | 0.4 mg/mL | |
protamine sulfate | Injection | 10 mg/mL | |
sodium calcium edetate | Injection | 200 mg/ml in 5-ml ampoule |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
sterile solution for irrigation | Solution for injection | 10mL | |
sterile solution for irrigation | Solution for injection | 50 mL |